Loading…

Dexamethasone for preventing postoperative nausea and vomiting after mastectomy

Postoperative nausea and vomiting (PONV) is a common complication after mastectomy. Although many researches have been studied the prophylactic effect of antiemetics, none of the results are effective. To overcome this problem, dexamethasone was used to relieve the occurrence of PONV. Since concerns...

Full description

Saved in:
Bibliographic Details
Published in:Medicine (Baltimore) 2020-07, Vol.99 (30), p.e21417-e21417
Main Authors: Xu, LeiLai, Xie, XiaoHong, Gu, XiDong
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4505-97a9c1d80ed6d7ffe3e198a1e23cedbd8945cb26682deb0a52d37fa6948834b53
cites cdi_FETCH-LOGICAL-c4505-97a9c1d80ed6d7ffe3e198a1e23cedbd8945cb26682deb0a52d37fa6948834b53
container_end_page e21417
container_issue 30
container_start_page e21417
container_title Medicine (Baltimore)
container_volume 99
creator Xu, LeiLai
Xie, XiaoHong
Gu, XiDong
description Postoperative nausea and vomiting (PONV) is a common complication after mastectomy. Although many researches have been studied the prophylactic effect of antiemetics, none of the results are effective. To overcome this problem, dexamethasone was used to relieve the occurrence of PONV. Since concerns about steroid-related morbidity still remain, We carried out a meta-analysis to evaluate the impact of prophylactic dexamethasone on PONV, post-operative pain undergoing mastectomy. Literature search was conducted through PubMed, Web of Science, EMBASE, MEDLINE, and Cochrane library database till June 2019 to identify eligible studies. Meanwhile, we also consulted some Chinese periodicals, such as China Academic Journals, Wanfang and Weipu. The research was reported according to the preferred reporting items for systematic reviews and meta-analysis guidelines. Randomized controlled trials were included in our meta-analysis. Meanwhile, the assessment of the risk of bias was conducted according to the Cochrane Handbook for Systematic Reviews of Interventions version. The pooled data are processed by software RevMan 5.3. Four studies with 490 patients were enrolled to this meta-analysis. Our study demonstrated that the dexamethasone group was significantly more effective than the placebo group in term of PONV (risk ratio [RR] = 0.46, 95% confidence intervals [CI]: 0.30-0.70, P = .0003), nausea (RR = 0.26, 95% CI: 0.10-0.68, P = .006) and vomiting (RR = 0.15, 95% CI: 0.04∼0.55, P = .004). The visual analog scale score was significantly diminished at 1 hour (weighted mean difference = -1.40, 95% CI: -1.53 to -1.26, P 
doi_str_mv 10.1097/MD.0000000000021417
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7387045</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2434485557</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4505-97a9c1d80ed6d7ffe3e198a1e23cedbd8945cb26682deb0a52d37fa6948834b53</originalsourceid><addsrcrecordid>eNpdkctO3UAMhkeoCA6XJ0BCWXYTmGsms0GqOIVWArGB9cjJOJy0SSadmRzK2xM4XFq8sWR__m35J-SI0RNGjT69Xp7Qj-BMMr1FFkyJIlemkF_IYq6qXBstd8lejL8oZUJzuUN2BdeGaWUW5GaJf6HHtILoB8waH7Ix4BqH1A732ehj8iMGSO0aswGmiJDB4LK179sXApqEIeshJqyT7x8PyHYDXcTD17xP7i6-357_yK9uLn-ef7vKa6moyo0GUzNXUnSF002DApkpgSEXNbrKlUaquuJFUXKHFQXFndANFEaWpZCVEvvkbKM7TlWPrp4PDtDZMbQ9hEfrobX_d4Z2Ze_92mpRaiqfBb6-CgT_Z8KYbN_GGrsOBvRTtFwKKUullJ5RsUHr4GMM2LyvYdQ-W2Gvl_azFfPU8b8Xvs-8_X4G5AZ48N38xPi7mx4w2BVCl1YvekobnnPKKZ1to_nsH1XiCc2Zlpg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2434485557</pqid></control><display><type>article</type><title>Dexamethasone for preventing postoperative nausea and vomiting after mastectomy</title><source>Open Access: PubMed Central</source><source>HEAL-Link subscriptions: Lippincott Williams &amp; Wilkins</source><source>IngentaConnect Journals</source><creator>Xu, LeiLai ; Xie, XiaoHong ; Gu, XiDong</creator><creatorcontrib>Xu, LeiLai ; Xie, XiaoHong ; Gu, XiDong</creatorcontrib><description>Postoperative nausea and vomiting (PONV) is a common complication after mastectomy. Although many researches have been studied the prophylactic effect of antiemetics, none of the results are effective. To overcome this problem, dexamethasone was used to relieve the occurrence of PONV. Since concerns about steroid-related morbidity still remain, We carried out a meta-analysis to evaluate the impact of prophylactic dexamethasone on PONV, post-operative pain undergoing mastectomy. Literature search was conducted through PubMed, Web of Science, EMBASE, MEDLINE, and Cochrane library database till June 2019 to identify eligible studies. Meanwhile, we also consulted some Chinese periodicals, such as China Academic Journals, Wanfang and Weipu. The research was reported according to the preferred reporting items for systematic reviews and meta-analysis guidelines. Randomized controlled trials were included in our meta-analysis. Meanwhile, the assessment of the risk of bias was conducted according to the Cochrane Handbook for Systematic Reviews of Interventions version. The pooled data are processed by software RevMan 5.3. Four studies with 490 patients were enrolled to this meta-analysis. Our study demonstrated that the dexamethasone group was significantly more effective than the placebo group in term of PONV (risk ratio [RR] = 0.46, 95% confidence intervals [CI]: 0.30-0.70, P = .0003), nausea (RR = 0.26, 95% CI: 0.10-0.68, P = .006) and vomiting (RR = 0.15, 95% CI: 0.04∼0.55, P = .004). The visual analog scale score was significantly diminished at 1 hour (weighted mean difference = -1.40, 95% CI: -1.53 to -1.26, P &lt; .00001) in the dexamethasone group, while, no statistically significant difference was observed between the two groups in terms of visual analog scale at 24 hours (weighted mean difference = -0.56, 95% CI: -1.24 to 0.13, P = 0.11). Not only does Dexamethasone reduce the incidence of PONV but also decreases postoperative pain. However, we still need larger samples and higher quality studies to determine the relationship between symptoms and administration time to reach the conclusion. PROSPERO CRD 42018118575.</description><identifier>ISSN: 0025-7974</identifier><identifier>ISSN: 1536-5964</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000021417</identifier><identifier>PMID: 32791759</identifier><language>eng</language><publisher>United States: the Author(s). Published by Wolters Kluwer Health, Inc</publisher><subject>Antiemetics - therapeutic use ; Dexamethasone - therapeutic use ; Humans ; Mastectomy - adverse effects ; Pain, Postoperative - etiology ; Pain, Postoperative - prevention &amp; control ; Postoperative Nausea and Vomiting - etiology ; Postoperative Nausea and Vomiting - prevention &amp; control ; Systematic Review and Meta-Analysis</subject><ispartof>Medicine (Baltimore), 2020-07, Vol.99 (30), p.e21417-e21417</ispartof><rights>the Author(s). Published by Wolters Kluwer Health, Inc.</rights><rights>Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4505-97a9c1d80ed6d7ffe3e198a1e23cedbd8945cb26682deb0a52d37fa6948834b53</citedby><cites>FETCH-LOGICAL-c4505-97a9c1d80ed6d7ffe3e198a1e23cedbd8945cb26682deb0a52d37fa6948834b53</cites><orcidid>0000-0003-3458-1862</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387045/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387045/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32791759$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Xu, LeiLai</creatorcontrib><creatorcontrib>Xie, XiaoHong</creatorcontrib><creatorcontrib>Gu, XiDong</creatorcontrib><title>Dexamethasone for preventing postoperative nausea and vomiting after mastectomy</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>Postoperative nausea and vomiting (PONV) is a common complication after mastectomy. Although many researches have been studied the prophylactic effect of antiemetics, none of the results are effective. To overcome this problem, dexamethasone was used to relieve the occurrence of PONV. Since concerns about steroid-related morbidity still remain, We carried out a meta-analysis to evaluate the impact of prophylactic dexamethasone on PONV, post-operative pain undergoing mastectomy. Literature search was conducted through PubMed, Web of Science, EMBASE, MEDLINE, and Cochrane library database till June 2019 to identify eligible studies. Meanwhile, we also consulted some Chinese periodicals, such as China Academic Journals, Wanfang and Weipu. The research was reported according to the preferred reporting items for systematic reviews and meta-analysis guidelines. Randomized controlled trials were included in our meta-analysis. Meanwhile, the assessment of the risk of bias was conducted according to the Cochrane Handbook for Systematic Reviews of Interventions version. The pooled data are processed by software RevMan 5.3. Four studies with 490 patients were enrolled to this meta-analysis. Our study demonstrated that the dexamethasone group was significantly more effective than the placebo group in term of PONV (risk ratio [RR] = 0.46, 95% confidence intervals [CI]: 0.30-0.70, P = .0003), nausea (RR = 0.26, 95% CI: 0.10-0.68, P = .006) and vomiting (RR = 0.15, 95% CI: 0.04∼0.55, P = .004). The visual analog scale score was significantly diminished at 1 hour (weighted mean difference = -1.40, 95% CI: -1.53 to -1.26, P &lt; .00001) in the dexamethasone group, while, no statistically significant difference was observed between the two groups in terms of visual analog scale at 24 hours (weighted mean difference = -0.56, 95% CI: -1.24 to 0.13, P = 0.11). Not only does Dexamethasone reduce the incidence of PONV but also decreases postoperative pain. However, we still need larger samples and higher quality studies to determine the relationship between symptoms and administration time to reach the conclusion. PROSPERO CRD 42018118575.</description><subject>Antiemetics - therapeutic use</subject><subject>Dexamethasone - therapeutic use</subject><subject>Humans</subject><subject>Mastectomy - adverse effects</subject><subject>Pain, Postoperative - etiology</subject><subject>Pain, Postoperative - prevention &amp; control</subject><subject>Postoperative Nausea and Vomiting - etiology</subject><subject>Postoperative Nausea and Vomiting - prevention &amp; control</subject><subject>Systematic Review and Meta-Analysis</subject><issn>0025-7974</issn><issn>1536-5964</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpdkctO3UAMhkeoCA6XJ0BCWXYTmGsms0GqOIVWArGB9cjJOJy0SSadmRzK2xM4XFq8sWR__m35J-SI0RNGjT69Xp7Qj-BMMr1FFkyJIlemkF_IYq6qXBstd8lejL8oZUJzuUN2BdeGaWUW5GaJf6HHtILoB8waH7Ix4BqH1A732ehj8iMGSO0aswGmiJDB4LK179sXApqEIeshJqyT7x8PyHYDXcTD17xP7i6-357_yK9uLn-ef7vKa6moyo0GUzNXUnSF002DApkpgSEXNbrKlUaquuJFUXKHFQXFndANFEaWpZCVEvvkbKM7TlWPrp4PDtDZMbQ9hEfrobX_d4Z2Ze_92mpRaiqfBb6-CgT_Z8KYbN_GGrsOBvRTtFwKKUullJ5RsUHr4GMM2LyvYdQ-W2Gvl_azFfPU8b8Xvs-8_X4G5AZ48N38xPi7mx4w2BVCl1YvekobnnPKKZ1to_nsH1XiCc2Zlpg</recordid><startdate>20200724</startdate><enddate>20200724</enddate><creator>Xu, LeiLai</creator><creator>Xie, XiaoHong</creator><creator>Gu, XiDong</creator><general>the Author(s). Published by Wolters Kluwer Health, Inc</general><general>Wolters Kluwer Health</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3458-1862</orcidid></search><sort><creationdate>20200724</creationdate><title>Dexamethasone for preventing postoperative nausea and vomiting after mastectomy</title><author>Xu, LeiLai ; Xie, XiaoHong ; Gu, XiDong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4505-97a9c1d80ed6d7ffe3e198a1e23cedbd8945cb26682deb0a52d37fa6948834b53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antiemetics - therapeutic use</topic><topic>Dexamethasone - therapeutic use</topic><topic>Humans</topic><topic>Mastectomy - adverse effects</topic><topic>Pain, Postoperative - etiology</topic><topic>Pain, Postoperative - prevention &amp; control</topic><topic>Postoperative Nausea and Vomiting - etiology</topic><topic>Postoperative Nausea and Vomiting - prevention &amp; control</topic><topic>Systematic Review and Meta-Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Xu, LeiLai</creatorcontrib><creatorcontrib>Xie, XiaoHong</creatorcontrib><creatorcontrib>Gu, XiDong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Xu, LeiLai</au><au>Xie, XiaoHong</au><au>Gu, XiDong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dexamethasone for preventing postoperative nausea and vomiting after mastectomy</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2020-07-24</date><risdate>2020</risdate><volume>99</volume><issue>30</issue><spage>e21417</spage><epage>e21417</epage><pages>e21417-e21417</pages><issn>0025-7974</issn><issn>1536-5964</issn><eissn>1536-5964</eissn><abstract>Postoperative nausea and vomiting (PONV) is a common complication after mastectomy. Although many researches have been studied the prophylactic effect of antiemetics, none of the results are effective. To overcome this problem, dexamethasone was used to relieve the occurrence of PONV. Since concerns about steroid-related morbidity still remain, We carried out a meta-analysis to evaluate the impact of prophylactic dexamethasone on PONV, post-operative pain undergoing mastectomy. Literature search was conducted through PubMed, Web of Science, EMBASE, MEDLINE, and Cochrane library database till June 2019 to identify eligible studies. Meanwhile, we also consulted some Chinese periodicals, such as China Academic Journals, Wanfang and Weipu. The research was reported according to the preferred reporting items for systematic reviews and meta-analysis guidelines. Randomized controlled trials were included in our meta-analysis. Meanwhile, the assessment of the risk of bias was conducted according to the Cochrane Handbook for Systematic Reviews of Interventions version. The pooled data are processed by software RevMan 5.3. Four studies with 490 patients were enrolled to this meta-analysis. Our study demonstrated that the dexamethasone group was significantly more effective than the placebo group in term of PONV (risk ratio [RR] = 0.46, 95% confidence intervals [CI]: 0.30-0.70, P = .0003), nausea (RR = 0.26, 95% CI: 0.10-0.68, P = .006) and vomiting (RR = 0.15, 95% CI: 0.04∼0.55, P = .004). The visual analog scale score was significantly diminished at 1 hour (weighted mean difference = -1.40, 95% CI: -1.53 to -1.26, P &lt; .00001) in the dexamethasone group, while, no statistically significant difference was observed between the two groups in terms of visual analog scale at 24 hours (weighted mean difference = -0.56, 95% CI: -1.24 to 0.13, P = 0.11). Not only does Dexamethasone reduce the incidence of PONV but also decreases postoperative pain. However, we still need larger samples and higher quality studies to determine the relationship between symptoms and administration time to reach the conclusion. PROSPERO CRD 42018118575.</abstract><cop>United States</cop><pub>the Author(s). Published by Wolters Kluwer Health, Inc</pub><pmid>32791759</pmid><doi>10.1097/MD.0000000000021417</doi><orcidid>https://orcid.org/0000-0003-3458-1862</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0025-7974
ispartof Medicine (Baltimore), 2020-07, Vol.99 (30), p.e21417-e21417
issn 0025-7974
1536-5964
1536-5964
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7387045
source Open Access: PubMed Central; HEAL-Link subscriptions: Lippincott Williams & Wilkins; IngentaConnect Journals
subjects Antiemetics - therapeutic use
Dexamethasone - therapeutic use
Humans
Mastectomy - adverse effects
Pain, Postoperative - etiology
Pain, Postoperative - prevention & control
Postoperative Nausea and Vomiting - etiology
Postoperative Nausea and Vomiting - prevention & control
Systematic Review and Meta-Analysis
title Dexamethasone for preventing postoperative nausea and vomiting after mastectomy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T04%3A29%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dexamethasone%20for%20preventing%20postoperative%20nausea%20and%20vomiting%20after%20mastectomy&rft.jtitle=Medicine%20(Baltimore)&rft.au=Xu,%20LeiLai&rft.date=2020-07-24&rft.volume=99&rft.issue=30&rft.spage=e21417&rft.epage=e21417&rft.pages=e21417-e21417&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000021417&rft_dat=%3Cproquest_pubme%3E2434485557%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4505-97a9c1d80ed6d7ffe3e198a1e23cedbd8945cb26682deb0a52d37fa6948834b53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2434485557&rft_id=info:pmid/32791759&rfr_iscdi=true